Clinical relevance of rifampicin-moxifloxacin interaction in isoniazid resistant/intolerant tuberculosis patients. Vogensen VB, Bolhuis MS, Sturkenboom MGG, van der Werf TS, et al. Antimicrob Agents Chemother 2021 Nov 22:AAC0182921. doi: 10.1128/AAC.01829.

Read + Share

Amedeo Smart

Independent Medical Education

Vogensen VB, Bolhuis MS, Sturkenboom MGG, van der Werf TS, et al. Clinical relevance of rifampicin-moxifloxacin interaction in isoniazid resistant/intolerant tuberculosis patients. Antimicrob Agents Chemother 2021 Nov 22:AAC0182921. doi: 10.1128/AAC.01829.
PMID: 34807758